On March 13, 2026, GE HealthCare Technologies Inc. announced the appointment of Kevin A. Lobo, the Chair and CEO of Stryker Corporation, to its Board of Directors. This strategic move is expected to enhance the company's governance and operational execution, given Lobo's extensive experience in the medical technology sector. With over 25 years of leadership experience, Lobo has a proven track record of driving innovation and scaling global businesses, which aligns with GE HealthCare's strategic priorities. His appointment comes at a time when the company is focusing on advancing its technology and improving patient care. Lobo's term will expire at the company's 2026 Annual Meeting of Stockholders, and he will also serve on the Talent, Culture, and Compensation Committee. The company has indicated that Lobo will receive compensation in accordance with its existing program for non-employee directors. Additionally, GE HealthCare will enter into an indemnification agreement with him, ensuring protection against potential liabilities arising from his role. This appointment is seen as a positive development for GE HealthCare, as it continues to build a more connected and sustainable future for healthcare. Furthermore, the company announced that two existing board members, Risa Lavizzo-Mourey and Tomislav Mihaljevic, will not seek re-election due to other commitments, which opens up opportunities for new leadership perspectives. Overall, Lobo's addition to the board is expected to have a small positive effect on the company's stock price, reflecting confidence in the company's direction and governance.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.